Answer
Moroctocog alfa replaces deficient factor VIII in haemophilia A; activated factor VIII helps activated factor IX convert factor X to activated factor X, which converts prothrombin to thrombin, allowing thrombin to convert fibrinogen into fibrin and form a clot.
Sources for this answer
- ReFacto AF 3000 IU powder and solvent for solution for injection in pre-filled syringePfizer Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 18Document updated
Sources checked